BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32000858)

  • 1. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
    Park HY; Kim KW; Yoon MA; Lee MH; Chae EJ; Lee JH; Chung HW; Yoon DH
    Cancer Imaging; 2020 Jan; 20(1):14. PubMed ID: 32000858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
    De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
    BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
    Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
    Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
    Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
    PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
    Lai AYT; Riddell A; Barwick T; Boyd K; Rockall A; Kaiser M; Koh DM; Saffar H; Yusuf S; Messiou C
    Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
    Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
    Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Whole-Body DWI and
    Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
    AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
    [No Abstract]   [Full Text] [Related]  

  • 10. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
    Almeida SD; Santinha J; Oliveira FPM; Ip J; Lisitskaya M; Lourenço J; Uysal A; Matos C; João C; Papanikolaou N
    Cancer Imaging; 2020 Jan; 20(1):6. PubMed ID: 31931880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.
    Han SN; Amant F; Michielsen K; De Keyzer F; Fieuws S; Van Calsteren K; Dresen RC; Gziri MM; Vandecaveye V
    Eur Radiol; 2018 May; 28(5):1862-1874. PubMed ID: 29218610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
    Dong H; Huang W; Ji X; Huang L; Zou D; Hao M; Deng S; Shen Z; Lu X; Wang J; Song Z; Zhang X; Xue H; Xia S
    AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
    [No Abstract]   [Full Text] [Related]  

  • 14. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
    Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
    Michielsen K; Dresen R; Vanslembrouck R; De Keyzer F; Amant F; Mussen E; Leunen K; Berteloot P; Moerman P; Vergote I; Vandecaveye V
    Eur J Cancer; 2017 Sep; 83():88-98. PubMed ID: 28734146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study.
    Rizzo S; De Piano F; Buscarino V; Pagan E; Bagnardi V; Zanagnolo V; Colombo N; Maggioni A; Del Grande M; Del Grande F; Bellomi M; Aletti G
    Eur J Radiol; 2020 Feb; 123():108786. PubMed ID: 31862634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of computed tomography and diffusion-weighted imaging as first-line imaging modality according to the International Myeloma Working Group (IMWG) imaging algorithm for monoclonal plasma cell disorders.
    Yoon MA; Chee CG; Chung HW; Lee DH; Kim KW
    Acta Radiol; 2022 May; 63(5):672-683. PubMed ID: 33853375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of whole-body 2-[
    Burns R; Mulé S; Blanc-Durand P; Tofighi M; Belhadj K; Zerbib P; Le Bras F; Baranes L; Haioun C; Itti E; Luciani A
    Eur Radiol; 2022 May; 32(5):3085-3096. PubMed ID: 34842956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
    Mosavi F; Laurell A; Ahlström H
    Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.